← Back to Search

Behavioural Intervention

Virtual Eye Rotation Vision Exercises (VERVE) for Convergence Insufficiency (VRVT - VERVE Trial)

Phase < 1
Recruiting
Led By Tara L Alvarez, PhD
Research Sponsored by OculoMotor Technologies
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 9 years and older
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 weeks post-therapy
Awards & highlights

VRVT - VERVE Trial Summary

This trial aims to study how treating eye coordination and focusing problems with virtual reality games can improve eye muscle responses and reduce eyestrain symptoms. The study will use a virtual reality headset to play a custom

Who is the study for?
This trial is for individuals aged 9 and older with eye coordination or focusing issues, specifically those with a CISS score of 16 or higher. Participants must have good vision (20/25) in each eye and be able to appreciate depth perception. They also need to understand the study and agree to participate.Check my eligibility
What is being tested?
The VERVE trial tests if playing a custom video game using virtual reality headsets can improve eye muscle responses and reduce eyestrain symptoms in people with eye movement disorders or convergence insufficiency.See study design
What are the potential side effects?
Potential side effects may include temporary discomfort like dizziness, headaches, or nausea due to the use of virtual reality headsets as well as possible eyestrain from engaging in vision exercises.

VRVT - VERVE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 9 years old or older.

VRVT - VERVE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 weeks post-therapy
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 weeks post-therapy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Near Point of Convergence
Positive Fusional Vergence
Secondary outcome measures
Convergence Insufficiency Symptom Survey (CISS)
Core Elements of Gaming Experience Questionnaire
Vision Quality of Life with Time Survey (VisQuaL-T)

VRVT - VERVE Trial Design

1Treatment groups
Experimental Treatment
Group I: Active Virtual Reality-Based Vision TherapyExperimental Treatment1 Intervention
Virtual reality vision therapy where participants will be playing a custom-designed video game to act as a therapeutic intervention on a consumer-available virtual reality headset.

Find a Location

Who is running the clinical trial?

OculoMotor TechnologiesLead Sponsor
New Jersey Institute of TechnologyOTHER
8 Previous Clinical Trials
893 Total Patients Enrolled
4 Trials studying Convergence Insufficiency
614 Patients Enrolled for Convergence Insufficiency
Salus UniversityOTHER
14 Previous Clinical Trials
927 Total Patients Enrolled
3 Trials studying Convergence Insufficiency
471 Patients Enrolled for Convergence Insufficiency

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Effectiveness of Virtual Reality Vision Therapy - VERVE
2021. "Effectiveness of Virtual Reality Vision Therapy - VERVE". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04691427.
All > Vision
~6 spots leftby Aug 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top